HomeBSX • NYSE
add
Boston Scientific Corporation
Previous close
$89.25
Day range
$89.10 - $90.39
Year range
$53.93 - $91.93
Market cap
134.07B USD
Avg Volume
6.92M
P/E ratio
74.57
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 4.21B | 19.34% |
Operating expense | 2.17B | 20.38% |
Net income | 469.00M | -7.13% |
Net profit margin | 11.14 | -22.21% |
Earnings per share | 0.63 | 26.00% |
EBITDA | 1.02B | 12.65% |
Effective tax rate | 29.90% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.50B | 162.82% |
Total assets | 38.08B | 11.85% |
Total liabilities | 17.12B | 14.80% |
Total equity | 20.96B | — |
Shares outstanding | 1.47B | — |
Price to book | 6.35 | — |
Return on assets | 4.77% | — |
Return on capital | 5.63% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 469.00M | -7.13% |
Cash from operations | 1.00B | 43.55% |
Cash from investing | -1.43B | -624.37% |
Cash from financing | 7.00M | -56.25% |
Net change in cash | -412.00M | -180.31% |
Free cash flow | 612.38M | 43.29% |
About
Boston Scientific Corporation, headquartered in Marlborough, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator which they call the EMBLEM subcutaneous implantable defibrillator. Wikipedia
Founded
Jun 29, 1979
Headquarters
Website
Employees
48,000